PeriGen and Qualcomm Enter Strategic Licensing Agreement
CARY, NC — February 28, 2018 — PeriGen, the innovator of advanced perinatal systems, today announced a strategic reseller agreement with Qualcomm Incorporated (NASDAQ:QCOM), through its wholly owned subsidiary, Qualcomm Life, Inc. PeriGen’s FDA-cleared software uses artificial intelligence to provide labor and delivery clinicians with real time analysis of dynamic patient data that has contributed to improved clinical and medical malpractice outcomes.
The collaboration with PeriGen will allow Qualcomm Life to license and sell PeriWatch™ Vigilance™, a new early warning platform for obstetrics that automatically identifies patients whose conditions are worsening, facilitating more timely interventions. PeriWatch Vigilance augments currently installed fetal surveillance systems, providing a critical layer of patient safety without requiring a hospital to “rip and replace” current systems. The “always on” software uses proprietary intelligent algorithms to analyze maternal vital signs, fetal heart rate, contractions and labor progress in real time, informing clinicians of emerging abnormalities. Specific thresholds and automated checklists can be configured according to each institution’s preferences. PeriGen’s solution will complement Qualcomm Life’s Capsule product line to make care inside the hospital more intelligent by leveraging connected device and system data.
“As we grow our intelligent care product platform, we look to collaborate with companies that monitor patients and provide actionable insights for physicians and care teams,” said James Mault, MD, FACS, senior vice president and chief medical officer of Qualcomm Life, Inc. “Our collaboration with PeriGen marks the first of Qualcomm Life’s obstetric applications and we are thrilled to be able to work with PeriGen in an effort to garner more insights for patients.”
“Clinicians are increasingly required to multitask, so the Vigilance early warning platform ensures that there is always a laser focus on spotting emerging issues and fostering communication and intervention before conditions worsen,” said Matthew Sappern, CEO of PeriGen. “We are excited to collaborate with Qualcomm Life, a company with the same vision of leveraging medical device data to the benefit of patients and their care teams.”
About Qualcomm
Qualcomm’s technologies powered the smartphone revolution and connected billions of people. We pioneered 3G and 4G – and now we are leading the way to 5G and a new era of intelligent, connected devices. Our products are revolutionizing industries, including automotive, computing, IoT, healthcare and data center, and are allowing millions of devices to connect with each other in ways never before imagined. Qualcomm Incorporated includes our licensing business, QTL, and the vast majority of our patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, all of our engineering, research and development functions, and all of our products and services businesses, including, our QCT semiconductor business. For more information, visit Qualcomm’s website, OnQ blog, Twitter and Facebook pages.
About PeriGen
PeriGen offers innovative perinatal software solutions that incorporate artificial intelligence (AI) features to enhance clinical efficiency and standardization of care during childbirth. Led by skilled OB practitioners and IT visionaries, PeriGen has created the PeriWatch platform to provide consistent analysis and efficient display of complex data in real-time to promote better human recognition and communication about impending problems during labor. With PeriWatch clinicians can spend more time on direct patient care and less time on manual calculations and data manipulation. To learn more, visit www.perigen.com; follow us on Twitter, LinkedIn, YouTube, and Facebook; or call 984.208.4250 or email.
